ORCHPHARMA.NSORCHPHARMA.NSNSE
Loading
EPS Diluted Over TimeContracting
Percentile Rank60
3Y CAGR-31.1%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
-31.1%/yr
vs +9.8%/yr prior
Acceleration
-40.9pp
Decelerating
Percentile
P60
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM3.72-81.1%
202519.65+3.1%
202419.06+67.9%
202311.35+2464.6%
2022-0.48+98.3%
2021-28.55-93.6%
2020-14.75-289.1%
20197.80+119.7%
2018-39.65+28.8%
2017-55.69-